GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Short-Term Debt

Prism Biolab Co (TSE:206A) Short-Term Debt : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Short-Term Debt?

Prism Biolab Co's Short-Term Debt for the quarter that ended in Sep. 2024 was 円0.0 Mil.


Prism Biolab Co Short-Term Debt Historical Data

The historical data trend for Prism Biolab Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Short-Term Debt Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
Short-Term Debt
- - -

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24
Short-Term Debt - - - -

Prism Biolab Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Prism Biolab Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines